Registry Report: Value of organ and tissue biovigilance. Catalan Biovigilance Report (2024) 2309 Read more about Registry Report: Value of organ and tissue biovigilance. Catalan Biovigilance Report (2024)
Registry Series: Organ donors with central nervous system tumors. Korean series (2020) 2182 Read more about Registry Series: Organ donors with central nervous system tumors. Korean series (2020)
Single center series (Abstract): Kidney transplantation from donors with a history of breast cancer (2008) 2173 Read more about Single center series (Abstract): Kidney transplantation from donors with a history of breast cancer (2008)
Registry Series: Donors with cancer. Italian series 2003-2010 (2012) 2162 Read more about Registry Series: Donors with cancer. Italian series 2003-2010 (2012)
Registry series: New Italian guidelines for donors with prostate cancer (2010) 2159 Read more about Registry series: New Italian guidelines for donors with prostate cancer (2010)
Registry Series: Malignancies in Deceased Organ Donors. Spanish Experience (2022) 2153 Read more about Registry Series: Malignancies in Deceased Organ Donors. Spanish Experience (2022)
Registry Series: Donor cancer transmission by organ transplantation. Australian experience (2021). 2152 Read more about Registry Series: Donor cancer transmission by organ transplantation. Australian experience (2021).
Registry series review: Heart transplants (adult) from donors with a history of cancer. Review of UNOS data 1987-2016 (2020) 2141 Read more about Registry series review: Heart transplants (adult) from donors with a history of cancer. Review of UNOS data 1987-2016 (2020)
Registry Series: Risk factors for Donor Derived Leukemia after Hematopoietic Cell Transplant (MDS) (2019) 2111 Read more about Registry Series: Risk factors for Donor Derived Leukemia after Hematopoietic Cell Transplant (MDS) (2019)
Registry Series: Risk factors for Donor Derived Leukemia after Hematopoietic Cell Transplant (CLL) (2019) 2110 Read more about Registry Series: Risk factors for Donor Derived Leukemia after Hematopoietic Cell Transplant (CLL) (2019)
